TY - JOUR
T1 - Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma
T2 - A systematic review and expert recommendations from the International SEARCH for CAYAHL Group
AU - Gowdy, S. Claire
AU - Flerlage, Jamie E.
AU - Seelisch, Jennifer
AU - Palese, Monica
AU - Bradshaw, Tyler
AU - Castellino, Sharon M.
AU - Cho, Steve
AU - Dieckmann, Karin
AU - Hoppe, Bradford S.
AU - Howard, Scott
AU - Kelly, Kara M.
AU - Kurch, Lars
AU - Lai, Hollie A.
AU - Lopci, Egesta
AU - Lucas, John T.
AU - Mauz-Körholz, Christine
AU - McCarten, Kathleen M.
AU - Pandit-Taskar, Neeta
AU - Schöder, Heiko
AU - Steglich, Jonas
AU - Stoevesandt, Dietrich
AU - Voss, Stephan D.
AU - Milgrom, Sarah A.
N1 - Publisher Copyright:
© 2026 The Author(s). British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.
PY - 2026/4
Y1 - 2026/4
N2 - In adults with classic Hodgkin lymphoma (cHL), metabolic tumour volume (MTV) is valuable for risk stratification. This systematic review explored the role of volumetric parameters in children, adolescents and young adults (CAYA) with cHL. This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method. Five databases were searched on 16 October 2024. Eligible studies were peer-reviewed manuscripts, written in English, published since database inception that included patients ≤21 years of age with a diagnosis of cHL treated with chemotherapy ± radiotherapy with a baseline 18F-Fluorodeoxyglucose (F-FDG) PET/CT scan for MTV quantification. The search strategy identified 3669 studies, of which 35 were eligible for inclusion. Fifteen studies (43%) evaluated a cohort exclusively ≤21 years of age. All eight studies that explored the association of baseline PET parameters with known risk factors identified a significant correlation. Nine of 12 papers (75%) demonstrated a statistically significant correlation with disease response to therapy on PET/CT. Fifteen of 20 papers (75%) demonstrated an independent statistically significant correlation with clinical outcomes. In the CAYAHL population, volumetric PET parameters are valuable for risk stratification despite heterogeneity in results. Future harmonization of the segmentation approach will facilitate incorporation of MTV into clinical practice.
AB - In adults with classic Hodgkin lymphoma (cHL), metabolic tumour volume (MTV) is valuable for risk stratification. This systematic review explored the role of volumetric parameters in children, adolescents and young adults (CAYA) with cHL. This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method. Five databases were searched on 16 October 2024. Eligible studies were peer-reviewed manuscripts, written in English, published since database inception that included patients ≤21 years of age with a diagnosis of cHL treated with chemotherapy ± radiotherapy with a baseline 18F-Fluorodeoxyglucose (F-FDG) PET/CT scan for MTV quantification. The search strategy identified 3669 studies, of which 35 were eligible for inclusion. Fifteen studies (43%) evaluated a cohort exclusively ≤21 years of age. All eight studies that explored the association of baseline PET parameters with known risk factors identified a significant correlation. Nine of 12 papers (75%) demonstrated a statistically significant correlation with disease response to therapy on PET/CT. Fifteen of 20 papers (75%) demonstrated an independent statistically significant correlation with clinical outcomes. In the CAYAHL population, volumetric PET parameters are valuable for risk stratification despite heterogeneity in results. Future harmonization of the segmentation approach will facilitate incorporation of MTV into clinical practice.
KW - Hodgkin lymphoma
KW - PET/CT
KW - adolescents and young adults
KW - children
KW - metabolic tumour volume
UR - https://www.scopus.com/pages/publications/105027788250
U2 - 10.1111/bjh.70329
DO - 10.1111/bjh.70329
M3 - Review article
C2 - 41535222
AN - SCOPUS:105027788250
SN - 0007-1048
VL - 208
SP - 1185
EP - 1195
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 4
ER -